Displaying drugs 8376 - 8400 of 10579 in total
4-iodo-acetamido phenylboronic acid
Experimental
Matched Name: … 4-iodo-acetamido phenylboronic acid …
Matched Iupac: … [3-(2-iodoacetamido)phenyl]boronic acid …
Matched Iupac: … [3-(2-iodoacetamido)phenyl]boronic acid …
(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE
Experimental
Matched Name: … (2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE …
Matched Iupac: … (2R)-2-phenyl-N-(pyridin-4-yl)butanamide …
Matched Iupac: … (2R)-2-phenyl-N-(pyridin-4-yl)butanamide …
N-[(4-methoxyphenyl)sulfonyl]-D-alanine
Experimental
Matched Name: … N-[(4-methoxyphenyl)sulfonyl]-D-alanine …
Matched Iupac: … (2R)-2-(4-methoxybenzenesulfonamido)propanoic acid …
Matched Iupac: … (2R)-2-(4-methoxybenzenesulfonamido)propanoic acid …
Giloralimab
Giloralimab is under investigation in clinical trial NCT04807972 (Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 Is Administered in Combination With IV Modified FOLFIRINOX (Mffx) With or Without IV Budigalimab Compared to Mffx in Adult Participants With Untreated Pancreatic Cancer Metastasis).
Investigational
Technetium TC-99M trofolastat
Investigational
Tilavonemab
Investigational
Matched Synonyms: … Immunoglobulin g4, anti-(human tau protein) (human-mus musculus monoclonal pr-1649264 .gamma.4-chain) …
Dazodalibep
Dazodalibep is under investigation in clinical trial NCT06104124 (A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity).
Investigational
Aspartic Acid-4-Carboxymethyl Ester
Experimental
Matched Name: … Aspartic Acid-4-Carboxymethyl Ester …
Matched Iupac: … (2S)-2-amino-4-(carboxymethoxy)-4-oxobutanoic acid …
Matched Iupac: … (2S)-2-amino-4-(carboxymethoxy)-4-oxobutanoic acid …
4-[(METHYLSULFONYL)AMINO]BENZOIC ACID
Experimental
Matched Name: … 4-[(METHYLSULFONYL)AMINO]BENZOIC ACID …
Matched Iupac: … 4-methanesulfonamidobenzoic acid …
Matched Iupac: … 4-methanesulfonamidobenzoic acid …
1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL
Experimental
Matched Name: … 1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL …
Matched Iupac: … 1-chloro-6-(4-hydroxyphenyl)naphthalen-2-ol …
Matched Iupac: … 1-chloro-6-(4-hydroxyphenyl)naphthalen-2-ol …
2,6-dibromo-4-[(E)-2-phenylethenyl]phenol
Experimental
Matched Name: … 2,6-dibromo-4-[(E)-2-phenylethenyl]phenol …
Matched Iupac: … 2,6-dibromo-4-[(1E)-2-phenylethenyl]phenol …
Matched Iupac: … 2,6-dibromo-4-[(1E)-2-phenylethenyl]phenol …
2-((4'-HYDROXYNAPHTHYL)-AZO)BENZOIC ACID
Experimental
Matched Name: … 2-((4'-HYDROXYNAPHTHYL)-AZO)BENZOIC ACID …
Matched Iupac: … 2-[(1E)-2-(4-hydroxynaphthalen-1-yl)diazen-1-yl]benzoic acid …
Matched Iupac: … 2-[(1E)-2-(4-hydroxynaphthalen-1-yl)diazen-1-yl]benzoic acid …
Liothyronine I-131
Liothyronine I-131 has been used in trials studying the treatment of Tricuspid Atresia and Heart Defects, Congenital.
Investigational
Matched Iupac: … (2S)-2-amino-3-{4-[4-hydroxy-3-(¹³¹I)iodophenoxy]-3,5-di(¹³¹I)iodophenyl}propanoic acid …
4-epi-vancosaminyl derivative of vancomycin
Experimental
Matched Name: … 4-epi-vancosaminyl derivative of vancomycin …
Matched Iupac: … ),35,37,46,49-pentadecaen-48-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-3-hydroxy-2,4-dimethyloxan ... -4-aminium ... 5-hydroxy-4,6-dimethyloxan-2-yl]oxy}-22-(carbamoylmethyl)-40-carboxy-5,15-dichloro-18,32,35,37-tetrahydroxy ... }.2^{14,17}.1^{8,12}.1^{29,33}.0^{10,25}.0^{34,39}]pentaconta-3,5,8,10,12(48),14,16,29(45),30,32,34(39 ... (2S,3R,4S,6S)-6-{[(2S,3R,4S,5S,6R)-2-{[(1S,2R,18R,19R,22S,25R,28R,40S)-2-{[(2R,4S,5R,6S)-4-azaniumyl- …
Matched Iupac: … ),35,37,46,49-pentadecaen-48-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-3-hydroxy-2,4-dimethyloxan ... -4-aminium ... 5-hydroxy-4,6-dimethyloxan-2-yl]oxy}-22-(carbamoylmethyl)-40-carboxy-5,15-dichloro-18,32,35,37-tetrahydroxy ... }.2^{14,17}.1^{8,12}.1^{29,33}.0^{10,25}.0^{34,39}]pentaconta-3,5,8,10,12(48),14,16,29(45),30,32,34(39 ... (2S,3R,4S,6S)-6-{[(2S,3R,4S,5S,6R)-2-{[(1S,2R,18R,19R,22S,25R,28R,40S)-2-{[(2R,4S,5R,6S)-4-azaniumyl- …
N-(1-adamantyl)-N'-(4-guanidinobenzyl)urea
Experimental
Matched Name: … N-(1-adamantyl)-N'-(4-guanidinobenzyl)urea …
Matched Iupac: … 3-(adamantan-1-yl)-1-({4-[(diaminomethylidene)amino]phenyl}methyl)urea …
Matched Iupac: … 3-(adamantan-1-yl)-1-({4-[(diaminomethylidene)amino]phenyl}methyl)urea …
4-Methylpiperazin-1-Yl Carbonyl Group
Experimental
Matched Name: … 4-Methylpiperazin-1-Yl Carbonyl Group …
Matched Iupac: … 4-methylpiperazine-1-carboxylic acid …
Matched Iupac: … 4-methylpiperazine-1-carboxylic acid …
4-Phospho-D-erythronohydroxamic acid
Experimental
Matched Name: … 4-Phospho-D-erythronohydroxamic acid …
Matched Iupac: … [(2R,3R)-2,3-dihydroxy-3-(hydroxycarbamoyl)propoxy]phosphonic acid …
Matched Iupac: … [(2R,3R)-2,3-dihydroxy-3-(hydroxycarbamoyl)propoxy]phosphonic acid …
Temafloxacin
Temafloxacin is an antibiotic agent belonging to the fluoroquinolone drug class. It was first approved for use in the U.S. market in 1992, but was withdrawn shortly due to the reports of serious adverse reactions, such as allergic reactions and hemolyric anemia, resulting in three deaths.
Withdrawn
Matched Iupac: … 1-(2,4-difluorophenyl)-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid …
Fleroxacin
Fleroxacin is a broad-spectrum antimicrobial fluoroquinolone. It strongly inhibits the DNA-supercoiling activity of DNA gyrase. Fleroxacin is not an inhibitor of CYP1A2.
Experimental
Matched Iupac: … 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid …
Difloxacin
Difloxacin is a synthetic fluoroquinolone used in veterinary. As an antibacterial, it presents a broad bactericidal spectrum and its effects are dependent on its concentration. However, it presents a reduced efficacy when compared to other fluoroquinolone antibacterials.
Vet approved
Matched Iupac: … 6-fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid …
Matched Salts cas: … 91296-86-5 …
Matched Salts cas: … 91296-86-5 …
Xeligekimab
Xeligekimab is under investigation in clinical trial NCT06028490 (A Study of Il4rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis.).
Investigational
Matched Synonyms: … Immunoglobulin g4 (235-proline), anti-(human interleukin 17a) (human monoclonal gr1501 .gamma.4-chain …
A-620223
Experimental
Matched Synonyms: … trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium …
Matched Iupac: … 2-(1-propylpiperidin-4-yl)-1H-1,3-benzodiazole-7-carboxamide …
Matched Iupac: … 2-(1-propylpiperidin-4-yl)-1H-1,3-benzodiazole-7-carboxamide …
ANX-005
Investigational
Displaying drugs 8376 - 8400 of 10579 in total